DCF — CENTURA PENROSE HOSPITAL
Enterprise Value: $-154.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-154.2M
Enterprise Value
$-70.1M
PV of Cash Flows
$-84.1M
PV of Terminal Value
$-135.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $834.0M | $5.4M | 1.0% | $-29.9M | $-27.1M |
| Year 2 | $859.0M | $14.2M | 2.0% | $-22.2M | $-18.3M |
| Year 3 | $884.7M | $23.5M | 3.0% | $-14.3M | $-10.8M |
| Year 4 | $911.3M | $28.7M | 3.0% | $-11.3M | $-7.7M |
| Year 5 | $938.6M | $31.9M | 3.0% | $-9.9M | $-6.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-154.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$809.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.0015318762079373765
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5